Less Ads, More Data, More Tools Register for FREE

PureTech Health affiliate Vedanta Biosciences awarded $5.8m grant

Thu, 05th Dec 2019 08:14

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Thursday that its affiliate, Vedanta Biosciences, has been awarded a $5.8m grant for its 'VE707' programme, targeting multidrug resistant infections.
The FTSE 250 company said the grant was awarded to Vedanta by Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which it described as a global non-profit partnership dedicated to accelerating early development in antibacterial research and development, to address the rising global threat of drug-resistant bacteria.

It said Vedanta Biosciences is eligible for $3.5m in further funding upon completion of specific milestones.

"Increasingly the human microbiome is being colonised by dangerous bacteria and other microorganisms that have developed resistance to antimicrobial drugs, mainly through poor global stewardship of antibiotics," said PureTech president and chief of business and strategy Bharatt Chowrira.

"This grant from CARB-X recognises Vedanta's unique platform and advanced understanding of the human gut microbiome for developing live biotherapeutic products with the potential to modulate the intestinal microbiome to address a range of significant human diseases and health issues, including drug-resistant pathogens."

Related Shares

More News
29 May 2024 21:30

IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics

PureTech Health PLC - London-listed Biotech company headquartered in Boston - Says Tuesday that founded entity, Ankili Inc, a game developer focusing ...

21 May 2024 14:07

PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug

(Alliance News) - PureTech Health PLC on Tuesday said that a company it founded and in which it maintains a stake had begun trials of a new treatment ...

20 May 2024 10:13

PureTech Health launches $100m tender offer

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase share...

20 May 2024 09:03

IN BRIEF: PureTech Health launches USD100 million buyback programme

PureTech Health PLC - London-based biotherapeutics company - Launches tender offer to repurchase shares for a maximum consideration of USD100 million....

10 May 2024 16:39

EARNINGS AND TRADING: Asiamet Resources declares special dividend

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.